{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T22:07:06Z","timestamp":1648764426103},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,11,9]],"date-time":"2007-11-09T00:00:00Z","timestamp":1194566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00277-007-0406-3","type":"journal-article","created":{"date-parts":[[2007,11,8]],"date-time":"2007-11-08T15:05:48Z","timestamp":1194534348000},"page":"391-395","source":"Crossref","is-referenced-by-count":5,"title":["Measuring holotranscobalamin II, an early indicator of negative vitamin B12 balance, by radioimmunoassay in patients with ischemic cerebrovascular disease"],"prefix":"10.1007","volume":"87","author":[{"given":"Songul","family":"Serefhanoglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismet","family":"Aydogdu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersoy","family":"Kekilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atilla","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,11,9]]},"reference":[{"key":"406_CR1","first-page":"147","volume":"354","author":"GJ Hankey","year":"1999","unstructured":"Hankey GJ, Warlow CP (1999) Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 354:147\u20131463","journal-title":"Lancet"},{"key":"406_CR2","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/01.STR.28.9.1840","volume":"28","author":"JP Whisnant","year":"1997","unstructured":"Whisnant JP (1997) Modeling of risk factors for ischaemic stroke. The Willis Lecture. Stroke 28:1839\u20131843","journal-title":"Stroke"},{"key":"406_CR3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s100720070098","volume":"21","author":"G Boysen","year":"2000","unstructured":"Boysen G, Truelsen T (2000) Prevention of recurrent stroke. Neurol Sci 21:67\u201372","journal-title":"Neurol Sci"},{"key":"406_CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ajh.2830340205","volume":"34","author":"J Lindenbaum","year":"1990","unstructured":"Lindenbaum J, Savage DG, Stabler SP, Allen RH (1990) Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid and total homocysteine concentrations. Am J Hematol 34:99\u2013107","journal-title":"Am J Hematol"},{"key":"406_CR5","first-page":"829","volume":"104","author":"V Herbert","year":"1984","unstructured":"Herbert V, Colman N, Palat D et al (1984) Is there a \u201cgold standard\u201d for human serum vitamin B12 assay? J Lab Clin Med 104:829\u2013841","journal-title":"J Lab Clin Med"},{"key":"406_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/clinchem\/45.2.189","volume":"45","author":"G Holleland","year":"1999","unstructured":"Holleland G, Schneede J et al (1999) Cobalamin deficiency in general practice. Assessment of the diagnostic Utility and Cost-Benefit Analysis of Methylmalonic acid determination in relation to current diagnostic strategies. Clin Chem 45:189\u2013198","journal-title":"Clin Chem"},{"key":"406_CR7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1373\/49.3.455","volume":"49","author":"S Loikas","year":"2003","unstructured":"Loikas S, L\u00f6pp\u00f6nen M, Suominen P, Moller J et al (2003) RIA for serum holo-transcobalamin: method evaluation in the clinical laboratory and reference \u00fdnterval. Clin Chem 49:455\u2013462","journal-title":"Clin Chem"},{"key":"406_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2796.2004.01437.x","volume":"257","author":"AM Hvas","year":"2005","unstructured":"Hvas AM, Nexo E (2005) Holotranscobalamin\u2014a first choice assay for diagnosing early vitamin B12 deficiency? J Intern Med 257:289\u2013298","journal-title":"J Intern Med"},{"key":"406_CR9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/07315724.1998.10718752","volume":"17","author":"H Baker","year":"1998","unstructured":"Baker H, Leevy CB, DeAngelis B, Frank O, Baker ER (1998) Cobalamin (vitamin B12) and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 17:235\u2013238","journal-title":"J Am Coll Nutr"},{"key":"406_CR10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1532-5415.1992.tb03641.x","volume":"40","author":"LC Pennypacker","year":"1992","unstructured":"Pennypacker LC, Allen RH, Kelly JP, Matthews LM, Grigsby J, Kaye K et al (1992) High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc 40:1197\u20131204","journal-title":"J Am Geriatr Soc"},{"key":"406_CR11","first-page":"35","volume":"36","author":"J Zittoun","year":"1999","unstructured":"Zittoun J, Zittoun R (1999) Modern clinical testing strategies in cobalamin and folate deficiency. Semin Hematol 36:35\u201346","journal-title":"Semin Hematol"},{"key":"406_CR12","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-124-5-199603010-00009","volume":"124","author":"R Gren","year":"1996","unstructured":"Gren R (1996) Screening for vitamin B12 deficiency: caveat emptor. Ann Intern Med 124:509\u2013511","journal-title":"Ann Intern Med"},{"key":"406_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM199707243370403","volume":"337","author":"O Nygard","year":"1977","unstructured":"Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1977) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230\u2013236","journal-title":"N Engl J Med"},{"key":"406_CR14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(02)00210-1","volume":"202","author":"Y Sato","year":"2002","unstructured":"Sato Y, Kaji M, Kondo I, Yoshida H, Satoh K, Metoki N (2002) Hyperhomocysteinemia in Japanese patients with convalescent stage ischaemic stroke: effect of combined therapy with folic acid and mecobalamine. J Neurol Sci 202:65\u201368","journal-title":"J Neurol Sci"},{"key":"406_CR15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1365-2710.1999.00244.x","volume":"24","author":"PK Sarkar","year":"1999","unstructured":"Sarkar PK, Lambert L (1999) Can lowering homocysteine levels reduce the incidence of stroke? J Clin Pharm Ther 24:331\u2013338","journal-title":"J Clin Pharm Ther"},{"key":"406_CR16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor vascular disease: probable benefits of increasing folic acid intakes. JAMA 274:1049\u20131057","journal-title":"JAMA"},{"key":"406_CR17","first-page":"473","volume":"114","author":"PM Ueland","year":"1989","unstructured":"Ueland PM, Refum H (1989) Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease and drug therapy. J Lab Clin Med 114:473\u2013501","journal-title":"J Lab Clin Med"},{"key":"406_CR18","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/clinchem\/48.3.526","volume":"48","author":"M Ulleland","year":"2002","unstructured":"Ulleland M, Eilersten I, Quadros EV, Rothenberg SP, Fedosov SN, Sundrehagen E et al (2002) Direct assay for cobalamin bound to transcobalamin (holo-transcobalamin) in serum. Clin Chem 48:526\u2013532","journal-title":"Clin Chem"},{"key":"406_CR19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/48.3.561","volume":"48","author":"E Nexo","year":"2002","unstructured":"Nexo E, Christensen A-L, Hvas A-M, Petersen TE, Fedosov S (2002) Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency. Clin Chem 48:561\u2013562","journal-title":"Clin Chem"},{"key":"406_CR20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.2830340210","volume":"34","author":"V Herbert","year":"1990","unstructured":"Herbert V, Fong W, Gulle V, Stopler T (1990) Low holotranscobalamin II is the earliest serum marker for subnormal vitamin B12 (cobalamin) absorption in patients with AIDS. Am J Hematol 34:132\u2013139","journal-title":"Am J Hematol"},{"key":"406_CR21","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/ajcn\/59.5.1213S","volume":"59","author":"V Herbert","year":"1994","unstructured":"Herbert V (1994) Staging vitamin B-12 (cobalamin) status in vegetarians. Am J Clin Nutr 59:1213\u20131222","journal-title":"Am J Clin Nutr"},{"key":"406_CR22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1212\/WNL.45.8.1435","volume":"45","author":"R Green","year":"1995","unstructured":"Green R, Kinsella LJ (1995) Current concept in the diagnosis of cobalamin deficiency. Neurology 45:1435\u20131440","journal-title":"Neurology"},{"key":"406_CR23","first-page":"69","volume":"20","author":"SS Kart\u0131","year":"2003","unstructured":"Kart\u0131 SS, Ratip S, Y\u0131lmaz M, Uk\u0131n\u00e7 K, \u00d6rem A, Ad\u0131g\u00fczel C et al (2003) Therapeutic trial of cobalamin in patients with normal serum cobalamin levels and predicted cobalamin deficiency. Turk J Haematol 20:69\u201374","journal-title":"Turk J Haematol"},{"key":"406_CR24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jcp.46.6.537","volume":"46","author":"SN Wickramasinghe","year":"1993","unstructured":"Wickramasinghe SN, Fida S (1993) Correlations between holo-transcobalamin II, holo-haptocorrin, and total B12 in serum samples from healthy subjects and patients. J Clin Pathol 46:537\u2013539","journal-title":"J Clin Pathol"},{"issue":"5","key":"406_CR25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00000441-199411000-00004","volume":"308","author":"DB Matchar","year":"1994","unstructured":"Matchar DB, McCrory DC, Millington DS, Feussner JR (1994) Performance of the serum cobalamin assay for diagnosis of cobalamin deficiency. Am J Med Sci 308(5):276\u2013283","journal-title":"Am J Med Sci"},{"issue":"11","key":"406_CR26","first-page":"1478","volume":"1","author":"W Herrmann","year":"2003","unstructured":"Herrmann W, Obeid R, Schorr H, Geisel J (2003) Functional vitamin B12 deficiency and determination of holotranscobalamin in populations at risk. Clin Chem Lab Med 1(11):1478\u20131488","journal-title":"Clin Chem Lab Med"},{"key":"406_CR27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000205559","volume":"81","author":"WG Thompson","year":"1989","unstructured":"Thompson WG, Cassino C, Babiutz L, Meola T, Berman R, Lipkin M Jr, Freedman M (1989) Hypersegmented neutrophils and vitamin B12 deficiency. Acta Haematol 81:186","journal-title":"Acta Haematol"},{"key":"406_CR28","first-page":"454","volume":"109","author":"R Carmel","year":"1987","unstructured":"Carmel R, Sinow RM, Karnaze DS (1987) Atypical cobalamin deficiency. Subtle biochemical evidence of deficiency is commonly demonstrable in patients without megaloblastic anemia and is often associated with protein-bound cobalamin malabsorption. J Lab Clin Med 109:454","journal-title":"J Lab Clin Med"},{"key":"406_CR29","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1001\/archinte.1988.00380080016007","volume":"148","author":"R Carmel","year":"1988","unstructured":"Carmel R (1988) Pernicious anemia\u2014the expected findings of very low serum cobalamin levels, anemia and macrocytosis are often lacking. Arch Intern Med 148:1712","journal-title":"Arch Intern Med"},{"issue":"26","key":"406_CR30","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM198806303182604","volume":"318","author":"J Lindenbaum","year":"1988","unstructured":"Lindenbaum J, Healton EB, Savage DG, Brust JCM, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH (1988) Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 318(26):1720","journal-title":"N Engl J Med"},{"issue":"5","key":"406_CR31","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/blood.V76.5.871.871","volume":"76","author":"SP Stabler","year":"1990","unstructured":"Stabler SP, Allen RH, Savage DG, Lindenbaum J (1990) Clinical spectrum and diagnosis of cobalamin deficiency. Blood 76(5):871\u2013881","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0406-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-007-0406-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-007-0406-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T23:57:53Z","timestamp":1588031873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-007-0406-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["406"],"URL":"https:\/\/doi.org\/10.1007\/s00277-007-0406-3","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,9]]}}}